welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
-
Ileal Reservoir with Ileo-Anal Anastomosis: Long-term ComplicationsColoproctectomy with ileo-anal anastomos...
-
Medication Education: F.A.P. and Medicationhttps://www.youtube.com/watch?v=UOQ94Rse...
-
Bonnies Diary Feb 08https://jtvcancersupport.com/embed/30453...
-
Anal Transitional Zone Neoplasia in Patients with Familial Adenomatous Polyposis After Restorative Proctocolectomy a...BACKGROUND : Restorative proctocolectomy...
-
The Safety and Efficacy of Celecoxib in Children with Familial Adenomatous PolyposisOBJECTIVES : Celecoxib is approved as an...
-
Rectal Eversion and Double-Stapled Ileal Pouch Anal Anastomosis in Familial Adenomatous Polyposis SyndromeINTRODUCTION : Surgery is the only treat...
-
A Randomized Controlled Trial of Eicosapentaenoic acid and/or Aspirin For Colorectal Adenoma Prevention During Colon...BACKGROUND: The naturally-occurring ome...